Search global stocks & ETFs...Ctrl K
Learn Mode
AVTR logo
Avantor IncAVTR
$10.32
$0.31 (3.097%)
at close
$10.36
$0.04 (0.397%)
after hours · 10:33 PM
General
Scores
Financials & KPIs
Dividends
Analyst
Insider
Updates
AVTR
Stock Profile
Market Cap
$7.05B
Industry
Life Sciences Tools & Services
EPS (TTM)
-$0.81
P/E (TTM)
0.00
Div & Yield
--
FCF Payout Ratio
--
P/S (TTM)
1.08
P/B
1.26
Revenue Growth (TTM)
-1.99%
EPS CAGR (3Y)
0.00%
Diluted Shares
676.80M
Ex-Dividend
--
Next Earnings
07-23
Forward P/E
12.03
Payout Ratio
--
P/FCF (TTM)
16.05
FCF Yield
6.23%
Earnings Yield
-7.83%
Revenue CAGR (3Y)
-3.72%
Recommended Metric
2.64
Average
Avantor Inc has seen its revenue decline by -1.99% over the past year, which means the company is losing sales/customers. However, it has seen its diluted average shares outstanding decrease by -0.82% over the past year, which suggests the company is buying back shares.
Valuation Score
Key Score
3.00
Average
Management
3.00
Average

Growth
5.00
Very Good

Profitability
3.00
Average
Fin. Health
2.00
Bad

Dividends
--
--

Analyst
4.00
Good
Revenue
Earnings
Free Cash Flow
Insider Transactions
Explore Insider Tab ›
Buy Transactions
Sell Transactions
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$10.32
Baseline
High
$19.95
93.31%
Avg
$10.46
1.38%
Low
$7.07
-31.49%
Analyst Ratings based on 25 Analysts
Strong Buy
3
12%
Buy
5
20%
Hold
15
60%
Sell
1
04%
Strong Sell
1
04%
Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.Read More

IPO Date
2019-05-17

Industry
Life Sciences Tools & Services

Total Employees
13,500

Exchange
New York Stock Exchange, Inc.

Reporting Currency
USD

GICS
Life Sciences Tools & Services

GICS Sub
Life Sciences Tools & Services

GICS Sector
Health Care

GICS Group
Pharmaceuticals, Biotechnology & Life Sciences